|
|
|
Volumn 23, Issue 2 SUPPL. 5, 1996, Pages 2-7
|
|
Update: Vinorelbine (Navelbine) in non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
LOMUSTINE;
METHOTREXATE;
MITOMYCIN;
NAVELBINE;
VINBLASTINE;
VINCA ALKALOID;
VINDESINE;
ADVANCED CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG METABOLISM;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG TISSUE LEVEL;
GRANULOCYTOPENIA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MULTICENTER STUDY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
AGRANULOCYTOSIS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CONTROLLED CLINICAL TRIALS;
EUROPE;
HUMANS;
LUNG NEOPLASMS;
MULTICENTER STUDIES;
RANDOMIZED CONTROLLED TRIALS;
REMISSION INDUCTION;
SAFETY;
SURVIVAL RATE;
UNITED STATES;
VINBLASTINE;
|
|
EID: 0029874635
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (28)
|
|
References (0)
|
